Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02901626 · ClinicalTrials.gov registry record · Phase 3
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 544
- Enrollment target
NCT02901626: Clinical Trial Phase 3 study, sponsored by The George Washington University Biostatistics Center.
NCT02901626 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 544 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02901626, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 544 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.
Primary Outcome
Participants who either delivered or experienced a fetal death prior to 37 weeks gestation.
Interventions
- DEVICE Arabin Cervical Pessary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2022-05-10 |
| Phase | Phase 3 |
Why NCT02901626 stopped before completion
NCT02901626 is an interventional study that assigns participants to a tested intervention. The registered 544 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 1 intervention - of which Arabin Cervical Pessary is the first listed.
NCT02901626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02901626 about?
NCT02901626 is a clinical study titled "A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix". The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.
What is the current status of trial NCT02901626?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 544 participants. The study started on 2017-02-14. Estimated completion is 2022-05-10.
What interventions are being tested in trial NCT02901626?
The interventions under investigation include: Arabin Cervical Pessary (DEVICE).
Who is sponsoring clinical trial NCT02901626?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02901626's enrollment target sits among peer trials
544 691st of 2000 higher than 1,307 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
- NCT06170437 · 544 participants · NA
Smoke-free Home Study in Subsidized Housing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI